z-logo
open-access-imgOpen Access
Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia
Author(s) -
Thomas Elter,
Julia Kilp,
Peter Borchmann,
H. Schulz,
Michael Hallek,
Andreas Engert
Publication year - 2009
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.13379
Subject(s) - alemtuzumab , fludarabine , chronic lymphocytic leukemia , medicine , monoclonal antibody , monoclonal , oncology , refractory (planetary science) , immunology , leukemia , cancer research , antibody , chemotherapy , biology , cyclophosphamide , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here